ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
Artrya Ltd
$4.440
+$0.060 (+1.37%)
Day Range
$4.260 – $4.440
52 Week Range
$1.080 – $6.490
Volume
295.81K
Avg Volume (10D)
1.08M
Market Cap
$723.56M
Price Chart
Market Statistics
Open$4.310
Previous Close$4.380
Day High$4.440
Day Low$4.260
52 Week High$6.490
52 Week Low$1.080
Valuation
Market Cap723.56M
Shares Outstanding162.96M
Price to Book7.75
Trading Activity
Volume295.81K
Value Traded1.29M
Bid$4.280 × 216
Ask$4.440 × 1,330
Performance
1 Day-2.88%
5 Day9.50%
13 Week-0.45%
52 Week291.07%
YTD-7.01%
Technical Indicators
RSI (14)39.94
50-Day SMA$5.123
200-Day SMA$4.103
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]